AAGILENT TECHNOLOGIES, INC.
Laboratory Analytical Instruments
- Revenue
- $6.9B
- 6.7% YoY
- Operating margin
- 21.3%
- 6.9% YoY
- EBITDA
- $1.8B
- 1.3% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 1.1×
- $1.9B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear120% of net incomeCash flow under 80% of net income
- Dilutive SBCClear2% of revenueOver 10% of revenue
- Payouts exceed cash flowClear45% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear36% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $6.3B | $6.8B | $6.8B | $6.5B | $6.9B | 6.7% |
| Operating income | $1.3B | $1.6B | $1.4B | $1.5B | $1.5B | 0.6% |
| Net income | $1.2B | $1.3B | $1.2B | $1.3B | $1.3B | 1.1% |
| Operating cash flow | $1.5B | $1.3B | $1.8B | $1.8B | $1.6B | 11% |
| Capex | $188M | $291M | $298M | $378M | $407M | 7.7% |
| Stock-based comp | $110M | $125M | $111M | $129M | $128M | 0.8% |
| Buybacks | $788M | $1.1B | $575M | $1.1B | $425M | 63% |
| Dividends | $236M | $250M | $265M | $274M | $282M | 2.9% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $96K · 1
- Net
- −$96K
Pay vs performance
No pay-versus-performance disclosure yet.